Search Results

You are looking at 21 - 30 of 60 items for :

  • Framingham risk score x
Clear All
Open access

Ivo S. Petrov, Arman Sh. Postadzhiyan, Mariya P. Tokmakova, Lyudmila G. Kitova, Svetlin N. Tsonev, Janet Addison, Reneta T. Petkova and Vasil I. Lachev

, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidemias: the Task Force for the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-1818. 9. Conroy R, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003. 10. D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Open access

Marijan Bosevski

? Int J Cardiol. 2009 Jan 9;131(2):290-2. 12. Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, Bakker SJ, de Zeeuw D. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study. Am J Kidney Dis. 2012 Nov;60(5):804-11 13. Chang A, Kramer H. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney diseaseand cardiovascular disease risk prediction. Nephron Clin Pract. 2011;119(2):c171-7; 14. Dzekova

Open access

Cristina Muntean, Adina Mitrea, Maria Mota and Valerica Tudorica

. Johnston S C, Rothwell P M, Nguyen - Huynh M N, Giles M F, Elkins J S, Bernstein A L. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet 369: 283-292, 2007. Holzer K, Feurer R, Sadikovic S, Esposito L, Bockelbrink A, Sander D, Hemmer B, Poppert H. Prognostic value of the ABCD2 score beyond short-term follow-up after transient ischemic attack (TIA) - a cohort study. BMC Neurology 10: 50, 2010. Feldmann E, Broderick J P, Kernan W N, Viscoli CM, Brass L M

Open access

Aysegul Kahraman, Hakan Akdam, Alper Alp, Mustafa Ahmet Huyut, Cagdas Akgullu, Tuba Balaban, Fadime Dinleyen, Aynur Topcu, Husniye Gelmez, Nevin Atakan, Harun Akar and Yavuz Yenicerioglu

hemodialysis patients. Am J Kidney Dis 1995; 25: 579-583. 7. Duranay M, Ozdemir O, Guler SC, Ecemis Z. Evaluation of nutritional parameters in hemodialysis patients. Turk Neph Dial Transpl 2004; 13: 16-20. 8. Sezer S, Arat Z, Ozdemir FN. Malnutrition in chronic renal failure. Turk Neph Dial Transpl 2000; 3: 125-129. 9. Sezer S, Ozdemir FN, Arat Z, et al. The Association of interdialytic weight gain with nutritional parameters and mortality risk in hemodialysis patients. Ren Fail 2002; 24: 37-48. 10. Demir M

Open access

Erzsébet Lázár, Lehel Bordi, István Benedek, Monica Chițu, Zsuzsanna Suciu, Tiberiu Nyulas, Roxana Hodas, Imre Benedek and István Benedek

J . 2012;33:1007-1016. 21. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol . 2007;49:1860-1870. 22. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA . 2004;291:210-215. 23. Arbab-Zadeh A, Fuster V. The Myth of the “Vulnerable Plaque”: transitioning from a focus on individual lesions to atherosclerotic disease

Open access

Oleg Sychov, Artem Borodai, Svetlana Fedkiv, Elina Borodai, Taisia Getman and Andrei Rybak

;272(1-2):36-42. [25] Kobayashi A, Iguchi M, Shimizu S, Uchiyama S. Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation. J Stroke Cerebrovasc Dis 2012;21(4):310-7. [26] Jeerakathil T, Wolf P, Beiser A, Massaro J, Seshadri S, D’Agostino R, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 2004;35(8):1857-61. [27] Pisters R, Olesen J, Lip G. The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it

Open access

Tamara Nikolic, Ivan Srejovic, Isidora Stojic, Jovana Jeremic, Marko Folic, Stevan Matic, Milena Rakocevic, Snezana Jancic, Biljana Jakovljevic, Radmila Obrenovic, Dusan Djuric and Vladimir Zivkovic

;47:407–409. 5. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart study. Can J Cardiol. 1988;4:5–10 6. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor to cardio vascular disease independent of high density lipoprotein cholesterol level: a meta analysis of population based prospective studies. J Cardiovasc Risk. 1996;3:213–219. 7. Guerin M, Legoff W, Lassel TS, VanTol A, Steiner G, Chapman MJ. Proatherogenic role of elevated CE transfer from HDL to VLDL and dense LDL in type 2 diabetics. Arterioscler

Open access

Andreia Pelegrini, Maria Fátima Glaner and Edio Luiz Petroski

. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R., High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med , 1977, 62, 707-714. 25. Bao W., Srinivasan S.R., Valdez R., Greenlund K.J., Wattigney W.A., Berenson G.S., Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease. The Bogalusa Heart Study. JAMA , 1997, 278 (21), 1749- 1754, doi: 10.1001/jama.1997.03550210047037. 26. Shepherd J., Cobbe

Open access

Paola Deambrosis, Alessandra Bettiol, Jenny Bolcato, Roberta Pirolo, Giulia Franchin, Sakis Themistoclakis, Michele Pellizzari, Alessandro Chinellato and Pietro Giusti

Primary and Secondary Care, National Institute for Health and Clinical Excellence, Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data, Thromb. Haemost. 99 (2008) 295-304; DOI: 10.1160/TH07-08-0508. 21. J. B. Olesen, C. Torp-Pedersen, M. L. Hansen and G. Y. Lip, The value of the CHA2DS2-VASC score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study, Thromb. Haemost. 107 (2012) 1172

Open access

Nóra Raț, Diana Opincariu, Emese Márton, Ramona Zavate, Mirela Pintican and Theodora Benedek

tomography angiography study. PLoS One . 2016;11:e0155120. 20. Nakanishi R, Rajani R, Cheng VY, et al. Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis . 2011;218:363-368. 21. Mahabadi A, Berg M, Lehmann N, et al. Association of Epicardial Fat With Cardiovascular Risk Factors and Incident Myocardial Infarction in the General Population: The Heinz Nixdorf Recall Study. Journal of the